NCT07288476 Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
| NCT ID | NCT07288476 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Pediatric Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-07-02 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-07-02 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Families of children with cancer who speak languages other than English experience inequalities in healthcare, but little research has been done on solutions to improve care for these families. This study will partner parents with medical interpreters and clinicians to create educational videos about key cancer topics in Spanish and test their use as a tool to improve caregiver knowledge and experience in the setting of a language barrier. The project will lead to a future career development award application that increases the number of available languages and studies how multilingual educational videos impact caregiver knowledge and experience
Eligibility Criteria
Inclusion Criteria: Aims 1 and 2 (Video Development Phase): * Legal caregiver aged ≥18 years of a child/young adult (0-25 years) undergoing active cancer treatment in low-intensity phases or off therapy. * Native or fluent Spanish speaker. * Willing and able to provide verbal consent. * Willing to comply with study procedures and be available for the study duration. Aim 3 (Video Pilot Phase): * Legal caregiver aged ≥18 years of a child/young adult (0-25 years) with newly diagnosed or relapsed/refractory cancer (≤1 month).N * Native or fluent Spanish speaker. * Requires an interpreter for medical conversations. * Willing and able to provide verbal consent. * Willing to comply with study procedures and be available for the study duration. Exclusion Criteria: Aims 1 and 2: * Insufficient cognitive functioning to complete study procedures (as determined by PI). * Caregiver of a child/young adult who did not receive cancer-directed therapy. * Caregiver of a child/young adult receiving high-intensity cancer treatment. * Unable to read and speak Spanish fluently. Aim 3: * Insufficient cognitive functioning to complete study measures (as determined by PI).Caregiver of a child/young adult who did not receive cancer-directed therapy. * Caregiver of a child/young adult not receiving cancer-directed therapy. * Diagnosis of new or relapsed/refractory cancer occurred \>1 month prior to enrollment. * Unable to speak Spanish fluently. * Does not require an interpreter for medical conversations.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07288476 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07288476 currently recruiting?
Yes, NCT07288476 is actively recruiting participants. Contact the research team at melanie.stall@childrenscolorado.org for enrollment information.
Where is the NCT07288476 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT07288476 clinical trial?
NCT07288476 is sponsored by University of Colorado, Denver. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.